Clinicopathological strategies to identify contralateral prostate cancer involvement in potential candidates for focal therapy

International Journal of Surgical Pathology

Volumn 18, Issue 6, 2010, Pages 499-507

  Grover, Sonal ^a   Srivastava, Abhishek ^a   Tan, Gerald ^a   Sooriakumaran, Prasanna ^a   John, Majnu ^a   Mudaliar, Kumaran ^a   El Douaihy, Youssef ^a   Leung, Robert ^a   Shevchuk, Maria ^a   Tewari, Ashutosh K ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

contralateral; extraprostatic extension; focal therapy; HGPIN; multifocal; prostate cancer

Indexed keywords

ADULT; ARTICLE; CANCER PATIENT; CANCER STAGING; DIGITAL RECTAL EXAMINATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PALPATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; ROBOTIC ASSISTED RADICAL PROSTATECTOMY;

AGED; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS;

EID: 78649268780     PISSN: 10668969     EISSN: 19402465     Source Type: Journal    
DOI: 10.1177/1066896910379479     Document Type: Article

References (23)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA Cancer J Clin. 2008 ; 58: 71-96.
2. SEER Cancer Statistics Review 1975-2006. http://seer.cancer.gov/ statfacts/html/prost.html?statfacts-page=prost.html&x=13&y=16. Retrieved July 26, 2010.
3. Smither AR, Guralnick ML, Davis NB, See WA Quantifying the natural history of post-radical prostatectomy incontinence using objective pad test data. BMC Urol. 2007: 7: 2.
4. Mettlin CJ, Murphy GP, Sylvester J., McKee RF, Morrow M., Winchester DP Results of hospital cancer registry surveys by the American College of Surgeons: outcomes of prostate cancer treatment by radical prostatectomy. Cancer. 1997 ; 80: 1875-1881.
5. Jayram G., Eggener SE Patient selection for focal therapy of localized prostate cancer. Curr Opin Urol. 2009 ; 19: 268-273.
6. Polascik TJ, Mayes JM, Schroeck FR, et al. Patient selection for hemiablative focal therapy of prostate cancer: variables predictive of tumor unilaterality based upon radical prostatectomy. Cancer. 2009 ; 115: 2104-2110.
7. Fukagai T., Namiki T., Namiki H., Carlile RG, Shimada M., Yoshida H. Discrepancies between Gleason scores of needle biopsy and radical prostatectomy specimens. Pathol Int. 2001 ; 51: 364-370.
8. Altay B., Kefi A., Nazli O., Killi R., Semerci B., Akar I. Comparison of Gleason scores from sextant prostate biopsies and radical prostatectomy specimens. Urol Int. 2001 ; 67: 14-18.
9. Montesino Semper M., Jimenez Aristu J., Reparaz Romero B., et al. Correlation between Gleason score on prostate biopsies diagnostic of adenocarcinoma and radical prostatectomy specimens [in Spanish]. Arch Esp Urol. 2004 ; 57: 519-523.
10. Arellano L., Castillo O., Metrebian E. Concordance of Gleason histological scoring for prostatic cancer in needle biopsies and the surgical piece obtained during radical prostatectomy [in Spanish]. Rev Med Chil. 2004 ; 132: 971-978.
11. Cookson MS, Fleshner NE, Soloway SM, Fair WR Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications. J Urol. 1997 ; 157: 559-562.
12. Moore R. The morphology of small prostatic cancenomas. J Urol. 1935 ; 33: 224.
13. Greene DR, Rogers E., Wessels EC, et al. Some small prostate cancers are nondiploid by nuclear image analysis: correlation of deoxyribonucleic acid ploidy status and pathological features. J Urol. 1994 ; 151: 1301-1307.
14. Wise AM, Stamey TA, McNeal JE, Clayton JL Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens. Urology. 2002 ; 60: 264-269.
15. Li TY, Lu XM, Su SW, et al. Detection of EBV-DNA, EBNA2 and LMP-1 in tumor tissues of han and uygur patients with nasopharyngeal carcinoma in Xinjiang [in Chinese]. Lin Chuang Er Bi Yan Hou Ke Za Zhi. 2000 ; 14: 76-77.
16. Meiers I., Waters DJ, Bostwick DG Preoperative prediction of multifocal prostate cancer and application of focal therapy: review 2007. Urology. 2007 ; 70: 3-8.
17. Mouraviev V., Mayes JM, Sun L., Madden JF, Moul JW, Polascik TJ Prostate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancer. Cancer. 2007 ; 110: 906-910.
18. Frota R., Stein RJ, Turna B., et al. Are prostate needle biopsies predictive of the laterality of significant cancer and positive surgical margins ? BJU Int. 2009 ; 104: 1599-1603.
19. Yoon GS, Wang W., Osunkoya AO, Lane Z., Partin AW, Epstein JI Residual tumor potentially left behind after local ablation therapy in prostate adenocarcinoma. J Urol. 2008 ; 179: 2203-2206.
20. Qian J., Wollan P., Bostwick DG The extent and multicentricity of high-grade prostatic intraepithelial neoplasia in clinically localized prostatic adenocarcinoma. Hum Pathol. 1997 ; 28: 143-148.
21. Tewari A., Horninger W., Badani KK, et al. Racial differences in serum prostate-specific antigen (PSA) doubling time, histopathological variables and long-term PSA recurrence between African-American and white American men undergoing radical prostatectomy for clinically localized prostate cancer. BJU Int. 2005 ; 96: 29-33.
22. Pierorazio PM, Lambert SM, Matsukhani M., et al. High-grade prostatic intraepithelial neoplasia is an independent predictor of outcome after radical prostatectomy. BJU Int. 2007 ; 100: 1066-1070.
23. Durkan GC, Sheikh N., Johnson P., Hildreth AJ, Greene DR Improving prostate cancer detection with an extended-core transrectal ultrasonography- guided prostate biopsy protocol. BJU Int. 2002 ; 89: 33-39.